MedPath

A Multicenter retrospective study to investigate the clinical significance of "suspicious for malignancy" on peritoneal washing cytology in resected pancreatic cancer

Not Applicable
Conditions
Patients diagnosed with resectable (R) or borderline resectable (BR) pancreatic cancer according to the General Rules for the Study of Pancreatic Cancer 7th edition written by Japan Pancreas Society, who performed upfront surgery, and diagnosed as suspicious or Class III (difficult to differentiate), Class IV (suspicious of malignancy), or Class V (positive/malignant) by peritoneal washing cytology on laparotomy.
Registration Number
JPRN-UMIN000046824
Lead Sponsor
niversity of Toyama
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who underwent neoadjuvant treatment Patients who have not undergone peritoneal washing cytology Patients with negative, Class I or II results on peritoneal washing cytology

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath